Renovaro Biosciences Net Income From Continuing Ops Over Time
| RENB Stock | 0.76 0.15 24.59% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Renovaro Biosciences Performance and Renovaro Biosciences Correlation. Renovaro |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renovaro Biosciences. If investors know Renovaro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renovaro Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Renovaro Biosciences is measured differently than its book value, which is the value of Renovaro that is recorded on the company's balance sheet. Investors also form their own opinion of Renovaro Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Renovaro Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renovaro Biosciences' market value can be influenced by many factors that don't directly affect Renovaro Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renovaro Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Renovaro Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renovaro Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Renovaro Biosciences and related stocks such as Allient, Mind Technology, and Viemed Healthcare Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNT | 17 M | 17 M | 17 M | 17 M | 17 M | 17 M | 17 M | 17 M | 17 M | 17 M | 13.6 M | 24.1 M | 17.4 M | 24.1 M | 21.2 M |
| MIND | 4.8 M | 4.8 M | 4.8 M | 4.8 M | (9.2 M) | (38.7 M) | (33.2 M) | (21.1 M) | (19.8 M) | (11.3 M) | (14 M) | (13.6 M) | (7.4 M) | (1.1 M) | (1.2 M) |
| VMD | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 1.2 M | 8.2 M | 10.2 M | 8.5 M | 31.5 M | 9.1 M | 6.2 M | 9.2 M | 11.5 M |
| ARW | 479.6 M | 598.2 M | 506.7 M | 399.9 M | 498.4 M | 503.5 M | 524.7 M | 407.2 M | 728.4 M | (175.3 M) | 589.3 M | 1.1 B | 1.4 B | 1.1 B | 681.5 M |
| CPIX | 5.6 M | 5.6 M | 5.8 M | (2.2 M) | 2.4 M | 671.1 K | (1 M) | (8 M) | (7 M) | (3.5 M) | (6.6 M) | (5.6 M) | (5.7 M) | (2.5 M) | (2.6 M) |
| PLTK | 257.4 M | 257.4 M | 257.4 M | 257.4 M | 257.4 M | 257.4 M | 257.4 M | 257.4 M | 338 M | 288.9 M | 92.1 M | 308.5 M | 275.3 M | 285.2 M | 210.9 M |
| CTLT | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 210.2 M | 111.2 M | 109.8 M | 83.6 M | 183.2 M | 220.7 M | 585 M | 519 M | 499 M | (1 B) | (990.9 M) |
| SCSC | 73.5 M | 74.3 M | 34.7 M | 81.8 M | 65.4 M | 63.6 M | 69.2 M | 33.2 M | 57.6 M | (79.2 M) | 45.4 M | 88.7 M | 88.1 M | 77.1 M | 44.2 M |
Renovaro Biosciences and related stocks such as Allient, Mind Technology, and Viemed Healthcare Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Renovaro Biosciences | RENB |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 0.76
Check out Renovaro Biosciences Performance and Renovaro Biosciences Correlation. For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Renovaro Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.